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In the past three months, I’ve prevented two people 
from going over, thanks to the training. Imagine how 
much devastation that would have caused otherwise.” 
Trainee
In 2010 the NTA helped 16 pilot sites across England 
to train the carers and relations of opiate misusers to 
respond to drug overdoses and use the antidote 
naloxone.
The project appears to have helped save lives. This was 
despite difficulties with recruitment, and limited 
evidence that carers are the most appropriate people 
to receive the training. While those carers who were 
trained said they found it valuable, a wider impact 
may be possible if the training focuses on all service 
users at risk of opioid overdose. 
An overview of the main findings of the project 
follows, along with advice for local areas interested in 
setting up their own training programmes for carers.
The appendices provide more detail about how the 
project was run and how the sites were evaluated.
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1. THE BACKGROUND
 • Naloxone is an antidote that rapidly, but temporarily, 
reverses the effects of heroin and other opioids 
Among the effects of heroin that can be reversed is 
suppressed breathing – meaning naloxone has the real 
potential to save lives
 • To avoid the risk of a further overdose after 
receiving naloxone, users should not take any more 
drugs. Even if naloxone has been used, an ambulance 
should always be called to an overdose so that further 
naloxone and other treatment can be administered if 
needed
 • Even though naloxone is a prescription-only 
medicine, with the right training anybody can use it 
“for the purpose of saving a life in an emergency” 
 • The first people to find overdosing drug users are 
often family members, partners and other carers (who 
may be drug users themselves). Research suggests 
many of them are willing to carry naloxone 
 • The 2007 UK Clinical Guidelines support the use of 
naloxone as a way of preventing fatal overdoses 
 • The NTA launched an overdose and naloxone 
training programme for family and carers of opiate 
users in 2009
 • The pilots ran at 16 sites in England from July 2009 
to February 2010. The NTA evaluated the results of the 
carers’ questionnaires and talked to the pilot leads and 
carers who went through the training
 • Details of the aims of the programme, and the 
methodology of the evaluation, are in Appendix 1, 
available at www.nta.nhs.uk.
2. THE RESULTS
 • At 16 pilot sites around England, 495 carers were 
trained to respond to an overdose using basic life 
support techniques. Those at 15 sites were also trained 
to administer naloxone
 • Following the training, and as of the date of this 
report, there have been 18 overdoses where carers 
used naloxone and two where they applied basic life 
support. All the drug users survived the overdose. Most 
of the incidents were ‘opportunistic’ interventions, 
where the carer used naloxone on somebody other 
than the person named on the prescription
 • It was more difficult to recruit carers for training than 
expected, but sites remained committed to running the 
training. Every site was able to train some carers 
 • Pilot leads and carers both felt it made sense to train 
those people most likely to be present when users were 
taking drugs and running the risk of an overdose – 
often family members, but also other users. Several 
sites trained pairs of mutual carers (partners, close 
friends, or housemates), who both received a naloxone 
supply. Some were former service users no longer at 
risk of overdose themselves, but who cared for 
somebody at risk 
 • For many, the training clarified the causes of overdose 
and dispelled myths about how to respond to an 
overdose. Several said that even if they forgot all else, 
they would remember how to use the naloxone
 • Parents said the training increased their knowledge 
around overdose, as well as feelings of empowerment 
and confidence. They felt that they now had a measure 
of control over their son or daughter’s drug use by 
being able to intervene in an overdose – whereas 
previously they had felt powerless. They said the 
training meant they were more willing to intervene in 
overdoses, and less concerned about using needles and 
triggering withdrawal symptoms in revived users 
 • Carers were trained in a variety of settings. One site 
trained carers from Portuguese and Italian communities. 
To successfully recruit them, they provided interpreters, 
and information leaflets in those languages
 • Another site targeted people who had just left 
inpatient detoxification, who have a high risk of 
overdose. The site found it difficult to engage these 
people, possibly because the stigma around drug use in 
their community (which was ethnically diverse, with a 
large Asian population) meant the family didn’t know 
the user was receiving treatment – the offer of training 
would have revealed this 
 • What’s more, detoxification was seen as the point 
beyond which the user would not take drugs again, so 
it was difficult to persuade users and their carers that 
the training was necessary. Despite this, the site 
worked with nine carers, showing them how the 
training could fit into a recovery plan for the user
 • It was challenging to provide training to carers of 
users about to leave three different prisons. At one site, 
family members were reluctant to have training at the 
same time as visiting relatives in prison, as this took 
time away from the visit itself. Trainers had to change 
their recruitment methods to increase interest in the 
training. At another, needles could not be provided to 
prisoners prior to release because of health and safety 
concerns (prisons have different rules on the possession 
and transfer of property, including needles and syringes)
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 • Some prisoners and family members were concerned 
the training implied they were either using drugs in 
prison, or would again after leaving. They feared this 
might affect the length of their sentence or eligibility 
for parole. However, pilot sites successfully promoted 
the training as a step towards recovery upon release, 
and a means of encouraging relatives to keep away 
from drugs after release, with overdose being an 
unexpected but potential occurrence
 • Most carers responded positively to the initial 
approach for training; but some sites reported that not 
all carers felt ready for training. Some, including a few 
with long histories of contact with carer support 
groups, found the subject too distressing to confront. 
Others whose adult children had overdosed (fatally and 
non-fatally) could clearly see naloxone’s potential for 
saving lives. Some also said their attendance on the 
training course had, in part, caused the user they care 
for to reduce or even stop taking drugs 
 • Other benefits included creating better contact 
between service users and treatment services, and 
more open dialogue between users and their carers 
about opiate misuse
 • Pilot sites found that the training worked well when 
provided alongside their other day-to-day drug 
treatment services 
 • All pilot leads who were interviewed said they 
wanted to continue training carers, subject to local 
funding and governance arrangements. Pilot leads 
recognised the value of training carers and said that if 
they were to do it again, they would include service 
users as well
 • The overall conclusion is that while training carers is 
beneficial in itself, training service users and providing 
overdose training and naloxone to as many people as 
possible may need to be considered to achieve a wider 
impact on overall fatal and non-fatal overdose rates.
3. POINTS TO CONSIDER FOR FUTURE 
TRAINING
These notes are for organisations that want to provide 
overdose response and naloxone training for carers. 
Several points may also apply if organisations want to 
train service users.
There are also considerations for commissioners, who 
assess local need and commission appropriate 
interventions to prevent drug-related deaths (one of the 
best practice outcomes in the 2010 Drug Strategy). 
Providing overdose response and naloxone training is 
one such intervention to consider. UK clinical guidelines, 
along with several published studies from around the 
world, make clear that take-home naloxone is a viable 
intervention in a package of measures to prevent 
drug-related deaths. However, it is difficult to prove the 
cost-effectiveness of naloxone, a point reflected in the 
lack of published research on the subject.
Questions that need answering
 • Do you have support from local commissioners, local 
medicines management, drug treatment services, drug 
partnership, and carer and service user organisations?
 • If providing training to carers of people in prison, 
what are the support and follow-up arrangements with 
community treatment services when the prisoner is 
released?
 • What knowledge of overdose response and 
naloxone do staff currently have? Will they benefit 
from training themselves?
 • Are there qualified trainers within the organisation? 
Will you need to improve the skills of current trainers, 
or bring in external trainers?
 • Do you have the capacity to set up and incorporate 
training into your existing service provision? Do you 
have a dedicated project lead or champion to ensure 
training has an impact? 
 • Do you have appropriate prescribing mechanisms – 
either direct prescribing to the patient, or providing 
naloxone using a Patient Group Direction (PGD) or 
Patient Specific Direction (PSD) with an appropriate 
informed consent process?
 • Have you checked there are no reported or expected 
naloxone shortages, and do you have contingency 
measures in case shortages do occur?
What is the definition of a carer? 
“[A] family member is defined as any adult person who 
is significant in the life of the drug user, irrespective of 
his or her biological, social or legal status. A carer is 
defined as anyone who cares for or offers support on a 
regular and personal basis to an individual, whether or 
not he or she has formal carer responsibilities and 
status.” 
Carers may include family members (parent, partner, 
sibling, son or daughter), housemates and close 
friends. These people may be former or current heroin 
users themselves. It is appropriate to train those most 
likely to be with an opiate user at the time of an 
overdose (that is, when they are using drugs). 
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Dedicated resources
Many sites said that having a dedicated programme 
lead for the pilot helped enormously, whether they 
worked solely on the pilot or had additional work 
commitments. Some sites that didn’t appoint a 
programme lead said their day-to-day work suffered, 
especially if they had little experience of training carers 
or service users. Most sites said they had 
underestimated, to a degree, the time and effort 
required to set up a training programme. 
One site said it helped to have champions at three 
strategic levels (consultant, managerial/staff, and service 
user). This meant the training was promoted effectively, 
and that any issues could be quickly addressed.
Gaining local support and securing naloxone 
supplies
Several sites said the key to success was getting 
approval from partner agencies, commissioners, local 
drug partnerships and primary care trusts (PCTs), and 
medicines management committees before training 
started. Some said the NTA’s endorsement and funding 
had helped to secure support from local stakeholders 
at the beginning and throughout the programme.
To take part in the NTA programme, sites had to show 
they had clinical leadership and competence in 
naloxone prescribing and overdose training. They also 
needed the backing of the local PCT, and specifically 
the pharmacy lead. Most sites implemented a PGD or 
PSD, which provided naloxone, usually via a non-
medical prescriber (NMP), in lieu of prescriptions. These 
arrangements were helped by support from medicines 
management committees. One site did not have this 
buy-in at an early stage and found it could not provide 
naloxone because of concerns about follow-up and 
aftercare.
Local areas planning future training may find it helpful 
to check there are no reported or expected naloxone 
shortages, and to have contingency measures in case 
shortages do occur. Supplies also need to be replaced 
once they expire (naloxone has a shelf life of two or 
three years) or are used. Sites sourced supplies from 
within the organisation providing the training, or from 
local hospitals or pharmacies. 
Supplying naloxone
 • Naloxone is a prescription-only medicine in England, 
although it may be used by anyone for the purpose of 
saving life in an emergency
 • It can be prescribed directly to a patient, or given via 
a PGD or PSD
 • Prescribers should only prescribe and supply 
naloxone to a known patient with a medical condition 
that requires the medication, and with the patient’s 
informed consent
 • This means naloxone cannot currently be prescribed 
(or supplied using a PGD/PSD) to a carer on behalf of a 
drug user, and cannot be given to a carer without the 
drug user’s informed consent.
 • The sites therefore had to fulfil three requirements 
before they could supply the drug:
1. The naloxone should be prescribed for a specific 
patient (or supplied by PGD/PSD) to an opiate user only 
2. This prescription should therefore be provided only 
with the opiate user’s informed consent
3. The opiate user needs to give written or verbal 
consent if a carer is to collect the naloxone on his or 
her behalf.
Four common approaches to supplying naloxone, using 
illustrative scenarios of what happened during the 
pilots, are included in Appendix 2.
Training staff 
Most sites also trained their staff. This ranged from 
‘training the trainers’ to one service training all their 
workers to use naloxone. As well as improving the skills 
of staff, this meant they could also promote the pilot 
during their day-to-day work. Several service users said 
they first heard about the training from a keyworker 
while visiting the service on another matter.
Several pilot leads said awareness of harm reduction 
and overdoses had improved among their staff, and 
that attitudes to the training had changed over time 
– at one site where a trainee used naloxone to reverse 
an overdose, staff became more supportive of the pilot 
and the demand for training went up. 
For some sites, the principles of harm reduction were 
already embedded among staff, but running the pilot 
added to their knowledge and training.
Recruiting carers
Pilot leads said promoting the training took a lot of 
effort. To begin with, attendance at some sessions was 
poor. A number of people found they couldn’t attend, 
or changed their minds. Pilot leads and trainers 
believed this reflected the often chaotic lifestyles of 
opiate users and the demanding job of caring for 
them. Much of the training also coincided with poor 
winter weather, which hit attendances hard.
Sites promoted the training with leaflets and posters, 
speaking at regional forums and meetings, and 
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information sessions for staff. Several carers (and users) 
in the focus groups said they got involved in training 
via their own keyworkers, or the keyworkers of the 
people they cared for. Some pilot leads attended local 
harm reduction and commissioning groups to promote 
the training. Others spoke to the police about what 
naloxone was and how it worked, should the police 
find it on someone and mistake it for an illicit drug. 
Some sites incentivised carers – for example, by paying 
travel costs. Others had good uptake without having to 
use such measures. Some felt incentives were 
inappropriate, and that the incentive to potentially save 
a life was sufficient.
What might a training session include?
At a minimum, it will be important to cover:  
a. Overdose and naloxone knowledge
At the end of the training session, carers will:
– Understand the causes of opiate overdose
– Know how to recognise overdoses and respiratory 
arrest
– Know what action to take in the event of an 
overdose
– Know what naloxone is and how it is used
– Have had myths and misconceptions about overdose 
and its treatment dispelled
– Have practised some basic first aid techniques
– Feel more confident in dealing with an overdose.
b. Managing an overdose
At the end of the training session, carers:
– Will know what to do if they see an overdose
– Are confident they can respond appropriately, 
including:
  Phoning 999 and asking for an ambulance
  Performing rescue breathing if needed
  Putting someone in the recovery position
  Knowing when to use naloxone.
c. Giving naloxone
At the end of the training session, carers know:
– Where to keep naloxone
– How to prepare a naloxone injection
– How and where to give naloxone
– How much naloxone to give and when to give 
another dose
– What to do when the user comes around, and what 
to do if they don’t.
In addition
 • To attract carers and make it easy for them to attend, 
provide training at a convenient time and location – ask 
for their views
 • Training carers in small groups, one-to-one, or in 
their homes, may be appropriate
 • Depending on who attends, adapt the content and 
length of the training session. For example:
– Are they family-member carers who are unfamiliar 
with using needles, or who may benefit from a longer 
session (for example, two hours) that includes drugs 
awareness training?  
– Are they carers who formerly used or currently use 
drugs, and may have experience of overdoses, but who 
might need longer to address overdose myths?
– Carers who formerly used or currently use drugs may 
benefit from shorter training sessions (e.g. an hour or 
under) that cover the basics of naloxone and advice on 
phoning an ambulance
– If the carers are not known to the organisation, a 
brief survey of their knowledge of drugs and/or 
overdose and naloxone will indicate what level to pitch 
the training 
– Sticking to agreed time limits will help carers who 
have limited availability, such as those in full-time 
employment 
– On the other hand, allowing sessions to overrun can 
help in certain situations, for example, when the 
content has been distressing for some carers and they 
need extra time for discussion either one-to-one or 
within the group 
– It may be useful to enhance the content of the 
training session to include more advanced first aid 
techniques such as CPR. 
Follow up 
Carers felt that contact should be maintained after 
training, and that refresher training should be provided 
around every six months. They said this ought to 
consist of a shortened version of the full training, but 
include any updates to basic life support techniques. 
Some also said they found it difficult to obtain new 
supplies of naloxone after they had used or misplaced 
their original supply.
For some, sharing their feelings since completing the 
training was an important process, as was hearing 
accounts of those who had used naloxone – they 
found this empowering, and it gave them extra 
assurance that the training worked in the ‘real world’.
Some sites did contact carers afterwards as part of the 
training package, but none planned to offer refresher 
training. Carers who received materials showing them 
how to provide basic life support and give naloxone 
(such as the Harm Reduction Works DVD, ‘Overdose 
and naloxone’) said that these helped them remember 
the training.
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Follow-up contact with carers can ensure local clinical 
protocols are met, such as providing support in case a 
fatal or non-fatal overdose occurs, and if naloxone is 
used. This contact can also be a crucial opportunity to 
provide refresher training and resupply naloxone. 
Carers may also welcome the opportunity to ‘debrief’ 
with a trainer or staff member if the naloxone is used. 
Carers and the people they care for can find it 
beneficial to share experiences in a group environment 
after training. 
More information
The appendices for this report are available at  
www.nta.nhs.uk. They are:
1. Aims and methodology
2. Guidance notes for naloxone supply
3. Questionnaire A – carers’ experience and 
demographics
4. Questionnaire B – ability, willingness, and concerns
5. Carers’ focus group questions
6. Pilot leads and trainers interview questions
7. List of pilot sites
8. Links and further reading.
